The University of Chicago Header Logo

Connection

Barry G. Arnason to Recurrence

This is a "connection" page, showing publications Barry G. Arnason has written about Recurrence.
Connection Strength

0.241
  1. MS Forum/MS Over the Past 17 Years. Int MS J. 2011 Sep; 17(3):76-82.
    View in: PubMed
    Score: 0.070
  2. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler. 2010 Jan; 16(1):30-8.
    View in: PubMed
    Score: 0.062
  3. Immunologic therapy of multiple sclerosis. Annu Rev Med. 1999; 50:291-302.
    View in: PubMed
    Score: 0.029
  4. Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. J Neurol. 2015 Nov; 262(11):2466-71.
    View in: PubMed
    Score: 0.023
  5. Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study. J Neurol. 2013 Jul; 260(7):1838-45.
    View in: PubMed
    Score: 0.019
  6. Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler. 2012 Feb; 18(2):181-95.
    View in: PubMed
    Score: 0.018
  7. T regulator cell surface antigens in multiple sclerosis. Ann N Y Acad Sci. 1984; 436:247-53.
    View in: PubMed
    Score: 0.010
  8. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci. 2002 Jan 01; 22(1):123-32.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.